A Novel Approach to Infectious Disease Preparedness: Incorporating Investigational Therapeutics and Research Objectives into Full-Scale Exercises
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Research">Research</a>
The use of investigational therapeutics in the care of patients with Ebola virus disease was documented in the literature following the 2013-2016 outbreak. In order to access these types of therapeutics, facilities must have processes in place to quickly and efficiently activate study protocols, obtain the medications, and administer them in a timely manner.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Angela+Vasa%2C+Syra+Madad%2C+LuAnn+Larson%2C+Colleen+S.+Kraft%2C+Sharon+Vanairsdale%2C+Jonathan+D.+Grein%2C+Jennifer+Garland%2C+Virginia+%E2%80%9CMadison%E2%80%9D+Butterworth%2C+and+Christopher+J.+Kratochvil.">Angela Vasa, Syra Madad, LuAnn Larson, Colleen S. Kraft, Sharon Vanairsdale, Jonathan D. Grein, Jennifer Garland, Virginia “Madison” Butterworth, and Christopher J. Kratochvil.</a>
2019-02-19
Y - D0.1Res/D0.2Res Qualtrics # 1306, original # 4
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=51&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Publication">Publication</a>
Are We Ready for the Next Outbreak?
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=General">General</a>
A three part pod-cast series discusses the need for new and improved tools to fight infectious disease, as demonstrated by the recent outbreaks of Ebola and Zika.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=U.S.+Agency+for+International+Development">U.S. Agency for International Development</a>
2018-04-01
2024-03-28 by J. Mundy – General subject – setting first review day 2025-01-01
2025-01-01
Prioritizing diseases for research and development in emergency contexts
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=General">General</a>
Worldwide, the number of potential pathogens is very large, while the resources for disease research and development (R&D) is limited. To ensure efforts under WHO’s R&D Blueprint are focused and productive, a list of diseases and pathogens are prioritized for R&D in public health emergency contexts.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=World+Health+Organization">World Health Organization</a>
2022
2024-03-28 by J. Mundy – General subject – setting first review day 2025-01-01
2025-01-01
Products Approved for Other Bioterrorism Emergencies
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Treatment+%26+Care">Treatment & Care</a>
This site lists products for Botulism due to Clostridium botulinum toxin; Ebola Virus Disease (EVD); Glanders and Melioidosis due to Burkholderia mallei and B. pseudomallei, respectively; Plague due to Yersinia pestis; Smallpox due to Variola major and Variola minor; Tularemia due to Francisella tularensis; and Zika Virus Disease.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=U.S.+Food+and+Drug+Administration">U.S. Food and Drug Administration</a>
2017-09-08
2022-09-27 - general asset review - Treatment & Care group
2025-09-27
After the Ebola Outbreak: Lessons Learned
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=General">General</a>
In the wake of caring for four patients with active Ebola virus in 2014, Emory clinicians have taken stock of lessons learned in infectious disease prevention, therapeutic care, and health aftereffects and are sharing that information broadly with other health care professionals and first responders.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Loftus%2C+Mary+%28editor%29%2C+Emory+Medicine">Loftus, Mary (editor), Emory Medicine</a>
2018-02-20
2022-01-10 by PPE group Shawn Gibbs
2025-01-10
The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Research">Research</a>
The current West Africa Ebola virus disease (EVD) outbreak has resulted in multiple individuals being medically evacuated to other countries for clinical management.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Kraft%2C+C.+S.%2C+A.+L.+Hewlett%2C+S.+Koepsell%2C+A.+M.+Winkler%2C+C.+J.+Kratochvil%2C+L.+Larson%2C+J.+B.+Varkey%2C+A.+K.+Mehta%2C+G.+M.+Lyon%2C+3rd%2C+R.+J.+Friedman-Moraco%2C+V.+C.+Marconi%2C+C.+E.+Hill%2C+J.+N.+Sullivan%2C+D.+W.+Johnson%2C+S.+J.+Lisco%2C+M.+J.+Mulligan%2C+T.+M.+Uyeki%2C+A.+K.+McElroy%2C+T.+Sealy%2C+S.+Campbell%2C+C.+Spiropoulou%2C+U.+Stroher%2C+I.+Crozier%2C+R.+Sacra%2C+M.+J.+Connor%2C+Jr.%2C+V.+Sueblinvong%2C+H.+A.+Franch%2C+P.+W.+Smith%2C+B.+S.+Ribner%2C+U.+Nebraska+Biocontainment+and+U.+the+Emory+Serious+Communicable+Diseases">Kraft, C. S., A. L. Hewlett, S. Koepsell, A. M. Winkler, C. J. Kratochvil, L. Larson, J. B. Varkey, A. K. Mehta, G. M. Lyon, 3rd, R. J. Friedman-Moraco, V. C. Marconi, C. E. Hill, J. N. Sullivan, D. W. Johnson, S. J. Lisco, M. J. Mulligan, T. M. Uyeki, A. K. McElroy, T. Sealy, S. Campbell, C. Spiropoulou, U. Stroher, I. Crozier, R. Sacra, M. J. Connor, Jr., V. Sueblinvong, H. A. Franch, P. W. Smith, B. S. Ribner, U. Nebraska Biocontainment and U. the Emory Serious Communicable Diseases</a>
2015-08-15
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=51&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Publication">Publication</a>
Editorial Commentary: Considerations of Favipiravir as a Medical Countermeasure in Future Randomized Controlled Trials Against Ebola Virus Disease
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Research">Research</a>
Since the discovery of Ebola virus in the Democratic Republic of Congo in 1976, outbreaks of EVD had been mainly confined to rural areas (http://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html)...
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Kraft%2C+C.+S.">Kraft, C. S.</a>
2016-11-15
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=51&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Publication">Publication</a>